-
Bond Announces Conversion of Outstanding Debt into Equity at Significant Premium to Market
June 16, 2026 08:07 ET | Source: Our Bond, Inc. Major Investor Exchanges Approximately $3.3 Million of Debt for Convertible Preferred Equity Priced at $2.0265 Per Common Share — a Premium of More Than 200% to Recent Trading Levels Above-Market Conversion Along With Separate Payment Schedule Adjustment Reduce 2026 Debt Burden By $4.3M, Reflecting Investors’…
-
Solidion Technology Announced AI-Assisted Design and Manufacturing Technology of Bipolar Solid-State Batteries for Space Vehicles, Ground, Sea, Air and Infrastructure
The company’s revolutionary, patented bipolar electrode-to-pack technology increases the battery energy and power densities; reducing weight, volume, and cost DALLAS, June 16, 2026 /PRNewswire/ — Solidion Technology, Inc. (Nasdaq: STI), an advanced battery technology solutions provider, today unveiled their patented bipolar electrode-to-pack (BEEP) battery technology, engineered to power electric vertical take-off and landing (eVTOL) aircraft,…
-
SoftServe Cuts AI Agent Deployment from Months to Four Weeks
New platform helps companies move AI agents out of test projects and into live operations, without building custom tools from scratch June 15, 2026 10:33 ET | Source: SoftServe, Inc AUSTIN, Texas, June 15, 2026 (GLOBE NEWSWIRE) — SoftServe, a digital engineering and technology services company, today released the SoftServe Agent Management Platform. It gives…
-
Menarini Group Reports Data from the Phase 3 SENTRY Trial of Selinexor Plus Ruxolitinib in Myelofibrosis at The European Hematology Association (EHA) 2026 Congress
The combination of selinexor plus ruxolitinib met the first co-primary endpoint demonstrating a statistically significant improvement of spleen volume reduction (SVR35) of 49.8% for the combination arm vs 28% for the control arm at week 24. Post-hoc analysis from the phase 3 SENTRY trial suggests SVR35 may predict overall survival (OS); new data from the…
-
Rocket Doctor Grants Stock Options and RSUs
June 12, 2026 17:13 ET | Source: Rocket Doctor AI Inc. Vancouver, BC, June 12, 2026 (GLOBE NEWSWIRE) — Rocket Doctor AI Inc. ( CSE: AIDR , OTC: AIRDF , Frankfurt: 939 ) (“Rocket Doctor AI”) has granted an aggregate 47,013 stock options, exercisable at $0.71 per share and valid for a term of three…
-
Exploratory Efficacy Data Suggests Further Study of Peanut Tolerance with Oral Mucosal Immunotherapy (OMIT)
NEW YORK, June 12, 2026 (GLOBE NEWSWIRE) — Intrommune Therapeutics, Inc., a clinical-stage biotechnology company committed to developing a patient-friendly treatment platform for people with peanut and other food allergies, today announced the presentation of exploratory efficacy data from the Oral Mucosal Escalation Goal Assessment (OMEGA) Phase 1 safety trial at the 2026 Eastern Allergy…
-
Published Study Shows Clinically Significant Energy, Performance, and Metabolic Benefits of FutureCeuticals’ Caffinity™
MOMENCE, Ill., June 10, 2026 /PRNewswire/ — FutureCeuticals, Inc. is pleased to announce the peer-reviewed publication of clinical research demonstrating unique energy, performance, and metabolic benefits of Caffinity™, a proprietary ingredient derived from the Arabica coffee cherry (bean and fruit). This study, conducted by recognized experts in energy metabolism at the University of Exeter (UK), establishes…
-
ARCPOINT ANNOUNCES APPOINTMENT OF PETER KENDALL AS INTERIM CHIEF EXECUTIVE OFFICER
June 09, 2026 19:00 ET | Source: ARCpoint Inc. GREENVILLE, South Carolina, June 09, 2026 (GLOBE NEWSWIRE) — ARCpoint Inc. (TSXV: ARC) (the “Company” or “ARCpoint”) announces that its Board of Directors has appointed Peter Kendall as Interim Chief Executive Officer of the Company, effective June 9, 2026. Mr. Kendall’s appointment remains subject to acceptance…
-
LENZ Therapeutics Announces Everest Medicines Acquired Rights to Develop and Commercialize VIZZ® (LNZ100) in Greater China
The New Drug Application for LNZ100 in China was submitted September 2025 with approval anticipated in Q1 2027 June 07, 2026 19:30 ET | Source: LENZ Therapeutics, Inc. SAN DIEGO, June 07, 2026 (GLOBE NEWSWIRE) — LENZ Therapeutics, Inc. (Nasdaq: LENZ, “LENZ” or the “Company”), a pharmaceutical company focused on the commercialization of VIZZ® (aceclidine…
-
Spring Break is Almost Here Dash through the "Titans" Forest on Awaji Island. "Attack on Titan" × Nijigen no Mori Runs Mar 14–Dec 13, Opening Highlight
Nijigen no Mori Inc. (Head Office: Awaji City, Hyogo Prefecture; President: Hiroshige Sadamatsu) is currently holding a limited-time collaboration event where guests can experience the world of TV anime “Attack on Titan” at Hyogo Prefectural Awajishima Park Anime Park “Nijigen no Mori” from Saturday, March 14, 2026 to Sunday, December 13, 2026. A Titan Appears…
-
"Attack on Titan" × Nijigen no Mori Collaboration Event Opens on Awaji Island, Japan, March 14-Dec 13, 2026
Nijigen no Mori Inc. (Head Office: Awaji City, Hyogo Prefecture; President: Hiroshige Sadamatsu) will host a limited-time collaboration event where guests can experience the world of the TV anime “Attack on Titan” at the Hyogo Prefectural Awajishima Park Anime Park “Nijigen no Mori” from tomorrow, Saturday, March 14, 2026 to Sunday, December 13, 2026. …
-
Solidion Technology’s 30+ Patents for Space-Based Artificial Intelligence Batteries Include the Highest-Performing Patented Lithium Anode Protection Technology
Game-Changing Anode Protection Platform Enabling All Ultra-High Energy Lithium Metal Batteries for Space and Commercial Applications DALLAS, June 5, 2026 /PRNewswire/ — Solidion Technology Inc. (“Solidion” or the “Company”) (NASDAQ: STI), an advanced battery technology solutions provider, today announced a patented breakthrough in lithium metal battery technology that removes the key stumbling blocks against full-scale…
-
Bluejay Diagnostics Announces Closing of Up to $23.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules
June 05, 2026 20:13 ET | Source: Bluejay Diagnostics, Inc. $8.5 million upfront with up to approximately $15.2 million of potential additional gross proceeds upon the exercise in full of warrants Net proceeds anticipated to extend cash runway into first quarter of 2027, beyond expected FDA submission; if warrants are exercised in full for cash,…
-
Fangzhou Showcases AI-Powered Chronic Disease Management Solution With Tencent Health at Tencent Cloud Conference
BEIJING, June 05, 2026 (GLOBE NEWSWIRE) — Fangzhou Inc. (“Fangzhou” or the “Company”) (HKEX: 06086), a leading provider of AI‑driven Internet healthcare solutions, attended the 2026 Tencent Cloud AI Industry Applications Summit in Beijing, where it showcased its “AI + Chronic Disease Services” digital solution developed in collaboration with Tencent Health. The conference, themed “Agent…
-
Solidion Technology Unveils Patented Extreme-Climate Battery Technology Targeting Low Earth Orbit-Based Artificial Intelligence Data Centers, Lunar Economy, and Space
Proprietary Gen-ECB Platform Engineered for Satellites, Starship Operations, Artemis Missions, and Orbital Infrastructure — Positioning Solidion at the Forefront of the Commercial Space Boom DALLAS, June 4, 2026 /PRNewswire/ — Solidion Technology Inc. (“Solidion” or the “Company”) (Nasdaq: STI), an advanced battery technology solutions provider, today announced a patented breakthrough in extreme-climate battery technology and…
-
Inc. Ranks CoreStack #65 to Its 2026 List of the Fastest-Growing Private Companies in the Pacific
CoreStack achieves 97% 2-Year Growth, earning this recognition for the 4th consecutive year. Bellevue, Washington, United States CoreStack, a global Agentic Governance OS provider, is excited to announce that it has been ranked No. 65 on sixth annual Inc. Regionals: Pacific list – the most prestigious ranking of the fastest-growing privately held companies in the…
-
Gaxos Secures Additional Funding from Amazon AWS to Accelerate AI Sales Platform Development
June 02, 2026 08:12 ET | Source: GAXOS.AI INC. Roseland, NJ, June 02, 2026 (GLOBE NEWSWIRE) — Gaxos.ai Inc. (“Gaxos” or the “Company”), a company developing artificial intelligence applications across various high-growth sectors, today announced that Amazon Web Services (“AWS”) has committed additional funding to accelerate Gaxos Labs’ AI-powered sales coaching platform. The additional AWS…
-
Silvio Napoli Assumes Role as CEO of Lucid Following Completion of Leadership Transition
NEWARK, Calif., June 1, 2026 /PRNewswire/ — Lucid Group, Inc. (NASDAQ: LCID), maker of the world’s most advanced software-defined vehicles and technologies, today announced that Silvio Napoli has assumed the role of Chief Executive Officer (CEO), effective immediately. Napoli was previously announced as incoming CEO on April 14. “On behalf of the Board, we are pleased…
-
MATTER Integrates Iontra's Battery Intelligence as one of the Core Layers of Its AI-Defined Vehicle (AIDV) Platform, Advancing AI-Governed Systems
Denver, USA | Ahmedabad, Gujarat, India A First-of-Its-Kind Initiative from India Towards AI-Governed Energy Systems in Mobility Battery intelligence becomes foundational to how energy is governed, protected, and evolved across MATTER’s electric two-wheelers MATTER, India’s technology-driven electric mobility company, and Iontra Inc, the industry leader in real-time battery sensing and charge control solution, today announced…
-
Servier to Acquire Edgewise Therapeutics’ Muscular Dystrophy Business
Acquisition supports Servier’s strategic ambition in rare neurology for patients with high unmet medical needs. Transaction includes sevasemten, a late-stage investigational treatment for Becker and Duchenne muscular dystrophies. Transaction represents total value of up to $2.65 billion. SURESNES, France, June 1, 2026 /PRNewswire/ — Servier, an independent international pharmaceutical group governed by a foundation, today announced that…
Latest News
About the Author
We increase the awareness of millions of users through our news networks. We are one of the most trusted news networks in the world.
